New Market Research Report: Cell Medica Limited - Product Pipeline Review - 2013

Global Markets Direct's pharmaceuticals report, "Cell Medica Limited - Product Pipeline Review - 2013" provides data on the Cell Medica Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Cell Medica Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Cell Medica Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Cell Medica Limited - Brief Cell Medica Limited overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Cell Medica Limited human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Cell Medica Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Cell Medica Limited's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- http://www.fastmr.com/prod/666780_cell_medica_limited_product_pipeline_review_2013.aspx?afid=301

Reasons to Get this Report

* Evaluate Cell Medica Limited's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Cell Medica Limited in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Cell Medica Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Cell Medica Limited.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Cell Medica Limited and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- T-Cell Lymphomas - Pipeline Review, H1 2013
- Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2013
- Mantle Cell Lymphoma - Pipeline Review, H2 2013
- Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013
- B-Cell Leukemia - Pipeline Review, H1 2013